About The Regents of The University of California
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The Regents of The University of California
During the past decade, The Regents of The University of California conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Regents of The University of California" #1 sponsor was "Shire" with 2 trials, followed by "Ampel BioSolutions, LLC" with 1 trials
sponsored, "Animas Corporation" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Chiesi USA, Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Regents of The University of California"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Oregon Health and Science University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at The Regents of The University of California
According to Clinical.Site data, the most researched conditions in "The Regents of The University of California" are
"Myocardial Infarction" (2 trials), "Ankylosing Spondylitis" (1 trials), "Arteriovenous Fistula" (1 trials), "Arteriovenous Graft" (1 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "The Regents of The University of California" in a lesser frequency.
Clinical Trials Intervention Types at The Regents of The University of California
Most popular intervention types in "The Regents of The University of California" are "Drug" (5 trials), "Biological" (3 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Participating Site's standard practice" (2 trials), "SRM003" (2 trials), "BMS-986165" (1 trials) and "Carotid Artery Stenting (CAS)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Regents of The University of California
The vast majority of trials in "The Regents of The University of California" are
10 trials for "All" genders.
Clinical Trials Status at The Regents of The University of California
Currently, there are NaN active trials in "The Regents of The University of California".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in The Regents of The University of California,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in The Regents of The University of California, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".